Erratum: A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis (Human Molecular Genetics (2008) vol. 17 (13) (1904-1915) 10.1093/hmg/ddn088);A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis

Human Molecular Genetics

Volumn 17, Issue 13, 2008, Pages 1904-1915

  Martin, Dianna C ^a   Atmuri, Vasantha ^a   Hemming, Richard J ^a   Farley, Judith ^b   Mort, John S ^b   Byers, Sharon ^c,d   Hombach klonisch, Sabine ^a   Stern, Robert ^e   Triggs raine, Barbara L ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIDASE; HYALURONIDASE 1; HYALURONIDASE 3; NEOMYCIN; PROTEOGLYCAN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; ENZYME ACTIVE SITE; ENZYME DEGRADATION; EPIPHYSIS; EXON; GENE CASSETTE; GENETIC CODE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; MOUSE; MUCOPOLYSACCHARIDOSIS; MUCOPOLYSACCHARIDOSIS IX; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TARGETING; WILD TYPE;

ANIMALIA; MURINAE; MUS; VERTEBRATA;

EID: 45749153385     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn207     Document Type: Erratum

References (60)

1. Neufeld, E.F. and Muenzer, J. (2001) In Scriver, C., Beaudet, A., Sly, W. and Valle, D. (eds), The Metabolic and Molecular Mechanisms of Inherited Disease, McGraw-Hill, New York, pp. 3421-3452.
2. Wraith, J.E. (1995) The mucopolysaccharidoses: A clinical review and guide to management. Arch. Dis. Child., 72, 263-267.
3. Natowicz, M.R., Short, M.P., Wang, Y., Dickersin, G.R., Gebhardt, M.C., Rosenthal, D.I., Sims, K.B. and Rosenberg, A.E. (1996) Clinical and biochemical manifestations of hyaluronidase deficiency. N. Engl. J. Med., 335, 1029-1033.
4. Triggs-Raine, B., Salo, T., Zhang, H., Wicklow, B.A. and Natowicz, M. (1999) Mutations in HYALI, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX. PNAS 96, 6296-6300.
5. Csoka, A.B., Frost, G.I. and Stern, R. (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol., 20, 499-508.
6. Kim, E., Baba, D., Kimura, M., Yamashita, M., Kashiwabara, S. and Baba, T. (2005) Identification of a hyaluronidase, Hya15, involved in penetration of mouse sperm through cumulus mass. Proc. Natl Acad. Sci. USA, 102, 18028-18033.
7. Fraser, J.R.E., Laurent, T.C. and Laurent, U.B.G. (1997) Hyaluronan: Its nature, distribution, functions and turnover. J. Int. Med., 242 27-33.
8. Fraser, J.R.E. and Laurent, T.C. (1989) Turnover and metabolism of hyaluronan. Ciba Found. Symp., 143, 41-59.
9. Fraser, J.R., Kimpton, W.G., Laurent, T.C., Cahill, R.N. and Vakakis, N. (1988) Uptake and degradation of hyaluronan in lymphatic tissue. Biochem. J., 256, 153-158.
10. Laurent, U.B., Dahl, L.B. and Reed, R.K. (1991) Catabolism of hyaluronan in rabbit skin takes place locally, in lymph nodes and liver. Exp. Physiol., 76, 695-703.
11. Laurent, U.B., Fraser, J.R., Engstrom-Laurent, A., Reed, R.K., Dahl, L.B. and Laurent, T.C. (1992) Catabolism of hyaluronan in the knee joint of the rabbit. Matrix, 12, 130-136.
12. Fraser, J.R., Appelgren, L.E. and Laurent, T.C. (1983) Tissue uptake of circulating hyaluronic acid. A whole body autoradiographic study. Cell Tissue Res., 233, 285-293.
13. Laurent, T.C. and Fraser, J.R. (1992) Hyaluronan. FASEB J., 6 2397-2404.
14. Zhou, B., Weigel, J.A., Fauss, L. and Weigel, P.R. (2000) Identification of the hyaluronan receptor for endocytosis (HARE). J. Biol. Chem., 275, 37733-37741.
15. Cully, M., Nguyen, H.A. and Underhill, C.B. (1992) The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol., 116, 1055-1062.
16. Csoka, A., Scherer, S.F. and Stern, R. (1999) Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics, 60, 356-361.
17. Frost, G.I., Csoka, T.B., Wong, T. and Stern, R. (1997) Purification, cloning, and expression of human plasma hyaluronidase. Biochem. Biophys. Res. Commun., 236, 10-15.
18. Lepperdinger, G., Strobl, B. and Kreil, G. (1998) HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J. Biol. Chem., 273, 22466-22470.
19. Rai, S.K, Duh, F.M., Vigdorovich, V., Danilkovitch-Miagkova, A., Lerman, M.I. and Miller, A.D. (2001) Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirtis, the envelope protein of which mediates oncogenic transformation. Proc. Natl Acad. Sci. USA, 98, 4443-4448.
20. Harada, H. and Takahashi, M. (2007) CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J. Biol. Chem., 282, 5597-5607.
21. Lokeshwar, V.B., Schroeder, G.L., Carey, R.I., Soloway, M.S. and Iida, N. (2002) Regulation of hyaluronidase activity by alternative mRNA splicing. J. Biol. Chem., 277, 33654-33663.
22. Roden, L., Campbell, P., Fraser, J.R.E., Laurent, T.C., Pertoft, H. and Thompson, J.N. (1989) Enzymic pathways of hyaluronan catabolism. Ciba Found. Symp., 143, 60-86.
23. Bourguignon, L.Y., Singleton, P.A., Diedrich, F., Stern, R. and Gilad, E. (2004) CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J. Biol. Chem., 279, 26991-27007.
24. Markovic-Housley, Z., Miglierini, G., Soldatova, L., Rizkallah, P.J., Muller, U. and Schirmer, T. (2000) Crystal structure of hyaluronidase, a major allergen of bee venom. Structure, 8, 1025-1035.
25. Shuttleworth, T.L., Wilson, M.D., Wicklow, B.A., Wilkins, J.A. and Triggs-Raine, B.L. (2002) Characterization of the murine hyaluronidase gene region reveals complex organization and cotranscription of Hyall with downstream genes, Fus2 and Hya13. J. Biol. Chem., 277, 23008-23018.
26. Dieppe, P.A. and Lohmander, L.S. (2005) Pathogenesis and management of pain in ostecarthritis. Lancet, 365, 965-973.
27. Aigner, T. and McKenna, L. (2002) Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol. Life Sci., 59, 5-18.
28. Haskins, M.E. (2007) Animal models for mucopolysaccharidosis disorders and their clinical relevance. Acta Paediatr. Suppl., 96, 56-62.
29. Tomatsu, S., Orii, K.O., Vogler, C., Nakayama, J., Levy, B., Grubb, J.H., Gutierrez, M.A., Shim, S., Yamaguchi, S., Nishioka, T. et al. (2003) Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease. Hum. Mol. Genet., 12, 3349-3358.
30. Ohshima, T., Murray, G.J., Swaim, W.D., Longenecker, G., Quirk, J.M., Cardarelli, C.O., Sugimoto, Y., Pastan, I., Gottesman, M.M., Brady, R.O. and Kulkami, A.B. (1997) Alpha-galactosidase A deficient mice: A model of Fabry disease. Proc. Natl Acad. Sci. USA, 94, 2540-2544.
31. Phaneuf, D., Wakamatsu, N., Huang, J.Q., Borowski, A., Peterson, A.C., Fortunato, S.R., Ritter, G., lgdoura, S.A., Morales, C.R., Benoit, G. et al. (1996) Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet., 5, 1-14.
32. Li, H.H., Yu, W.H., Rozengurt, N., Zhao, H.Z., Lyons, K.M., Anagnostaras, S., Fanselow, M.S., Suzuki, K., Vanier, M.T. and Neufeld, E.F. (1999) Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc. Natl Acad. Sci. USA, 96, 14505-14510.
33. Clarke, L.A., Russell, C.S., Pownall, S., Warrington, C.L., Borowski, A., Dimmick, J.E., Toone, J. and Jirik, F.R. (1997) Murine mucopolysaccharidosis type I: Targeted disruption of the murine alpha-L-iduronidase gene. Hum. Mol. Genet., 6, 503-511.
34. Garcia, A.R., Pan, J., Lamsa, J.C. and Muenzer, J. (2007) The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome). J. Inherit. Metab. Dis., 30, 924-934.
35. Evers, M., Saftig, P., Schmidt, P., Hafher, A., McLoghlin, D.B., Schmahl, W., Hess, B., von, F.K. and Peters, C. (1996) Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI. Proc. Natl Acad. Sci. USA, 93, 8214-8219.
36. Vogler, C., Birkenmeier, E.H., Sly, W.S., Levy, B., Pegors, C., Kyle, J.W. and Beamer, W.G. (1990) A murine model of mucopolysaccharidosis VII. Gross and microscopic findings in beta-glucuronidase-deficient mice. Am. J. Pathol., 136, 207-217.
37. Russell, C., Hendson, G., Jevon, G., Matlock, T., Yu, J., Aklujkar, M., Ng, K.Y. and Clarke, L.A. (1998) Murine MPS 1: Insights into the pathogenesis of Hurler syndrome. Clin. Genet., 53, 349-361.
38. Simonaro, C.M., Haskins, M.E. and Schuchman, E.H. (2001) Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: A possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab. Invest., 81 1319-1328.
39. Holmes, M.W., Bayliss, M.T. and Muir, H. (1988) Hyaluronic acid in human articular cartilage. Age-related changes in content and size. Biochem. J., 250, 435-441.
40. Brown, T.J., Laurent, U.B. and Fraser, J.R. (1991) Turnover of hyaluronan in synovial joints: Elimination of labelled hyaluronan from the knee joint of the rabbit. Exp. Physiol., 76, 125-134.
41. Antonas, K.N., Fraser, J.R. and Muirden, K.D. (1973) Distribution of biologically labelled radioactive hyaluronic acid injected into joints. Ann. Rheum. Dis., 32, 103-111.
42. Tanimoto, K., Suzuki, A., Ohno, S., Honda, K., Tanaka, N., Doi, T., Nakahara-Ohno, M., Yoneno, K., Nakatani, Y., Ueki, M. et al. (2004) Hyaluronidase expression in cultured growth plate chondrocytes during differentiation. Cell Tissue Res., 318, 335-342.
43. Nicoll, S.B., Barak, O., Csoka, A.B., Bhatnagar, R.S. and Stem, R. (2002) Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem. Biophys. Res. Commun., 292, 819-825.
44. Flannery, C.R., Little, C.B.H.C.E. and Caterson, B. (1998) Expression and activity of articular cartilage hyaluronidases. Biochem. Biophys. Res. Commun., 251, 824-829.
45. Bastow, E.R., Byers, S., Golub, S.B., Clarkin, C.E., Pitsillides, A.A. and Fosang, A.J. (2008) Hyaluronan synthesis and degradation in cartilage and bone. Cell Mol. Life Sci., 65, 395-413.
46. Roberts, A.L., Rees, M.H., Klebe, S., Fletcher, J.M. and Byers, S. (2007) Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA. Mol. Genet. Metab., 92, 115-121.
47. Venn, G. and Mason, R.M. (1985) Absence of keratan sulphate from skeletal tissues of mouse and rat. Biochem. J., 228, 443-450.
48. Hemming, R., Martin, D.C., Slominski, E., Nagy, J.I., Halayko, A.J., Pind, S. and Triggs-Raine, B. (2008) Mouse Hya13 encodes a 45-56 kDa. glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells. Glycobiology, 2008 Jan 30; [Epub ahead of print].
49. Sambrook, J. and Russell, D.W. (2001) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York, NY.
50. Mullenbach, R., Lagoda, P.J. and Welter, C. (1989) An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet., 5, 391.
51. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
52. Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
53. Miura, R.O., Yamagata, S., Miura, Y., Harada, T. and Yamagata, T. (1995) Analysis of glycosaminogycan-degrading enzymes by substrate gel electrophoresis (zymography). Anal. Biochem., 225, 333-340.
54. Armed Forces Institute of Pathology (1994) Laboratory Methods in Histotechnology. American Registry of Pathology, Washington, D.C.
55. Parkkinen, J.J., Hakkinen, T.P., Savolainen, S., Wang, C., Tammi, R., Agren, U.M., Lammi, M.J., Arokoski, J., Helminen, H.J. and Tammi, M.I. (1996) Distribution of hyaluronan in articular cartilage as probed by a biotinylated binding region of aggrecan. Histochem. Cell Biol., 105, 187-194.
56. Blumenkrantz, N. and Asboe-Hansen, G. (1973) New method for quantitative determination of uronic acids. Anal. Biochem., 54, 484-489.
57. Plaas, A.H., West, L., Midura, R.J. and Hascall, V.C. (2001) Disaccharide composition of hyaluronan and chondroitin/dermatan sulfate. Analysis with fluorophore-assisted carbohydrate electrophoresis. Methods Mol. Biol., 171, 117-128.
58. Karousou, E.G., Porta, G., De, L.G. and Passi, A. (2004) Analysis of fluorophore-labelled hyaluronan and chondroitin sulfate disaccharides in biological samples. J. Pharm. Biomed. Anal., 34, 791-795.
59. Shapira, E., Blitzer, M.G., Miller, J.B. and Africk, D.K. (1989) Biochemical Genetics: A Laboratory Manual, Oxford University Press, New York, NY.
60. Pfaffl, M.W., Horgan, G.W. and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36.